TNNT2 rs121913637: Understanding This Rare Cardiac Variant
The rs121913637 variant is a rare genetic alteration in the TNNT2 gene that results in an amino acid change known as Arg92Trp. This specific variant has been identified in clinical research as a pathogenic factor associated with familial hypertrophic cardiomyopathy and dilated cardiomyopathy.
What each genotype means
Typical cardiac risk profile
This genotype represents the common, non-pathogenic version of the TNNT2 gene at this location. It is not associated with the specific cardiac conditions linked to the Arg92Trp mutation.
This is the most common genotype, found in the vast majority of the global population.
Increased cardiomyopathy risk
This genotype corresponds to the Arg92Trp mutation, which is a known pathogenic variant linked to familial hypertrophic cardiomyopathy and dilated cardiomyopathy. Individuals with this variant should consult with a cardiologist or genetic counselor to discuss clinical screening and long-term heart health monitoring.
This genotype is extremely rare in global populations and is absent or near-zero in large-scale databases like gnomAD.
What is the rs121913637 Variant?
The rs121913637 variant is a specific change in the DNA sequence of the TNNT2 gene. In genetic terms, this is classified as a missense mutation, meaning that a single nucleotide substitution leads to the replacement of one amino acid with another in the resulting protein. Specifically, this variant causes an arginine to tryptophan substitution at position 92 (Arg92Trp) of the cardiac troponin T protein. Because this change occurs in a critical region of the protein, it can alter the protein's structure and function within the heart muscle. This variant is cataloged in medical databases as a pathogenic finding, meaning it is strongly linked to specific heart conditions in individuals who carry it. It is important to note that genetic variants like this are typically identified through clinical testing in families with a history of heart disease rather than through routine population screening.
The Role of the TNNT2 Gene
The TNNT2 gene provides the essential instructions for building a protein called cardiac troponin T. This protein is a vital component of the troponin complex, which is found exclusively in cardiac muscle cells. The troponin complex acts as a molecular switch, regulating the contraction and relaxation of the heart muscle by responding to calcium levels. When the heart receives an electrical signal, the troponin complex allows the muscle fibers to slide past one another, causing the heart to beat. Because cardiac troponin T is so central to the mechanical function of the heart, any structural change to this protein can disrupt the delicate process of muscle contraction. Research has shown that mutations in TNNT2 can lead to various forms of cardiomyopathy, which are diseases of the heart muscle that make it harder for the heart to pump blood effectively to the rest of the body.
Research and Clinical Associations
Scientific research has established a link between the Arg92Trp variant in TNNT2 and two primary types of heart muscle disease: hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM). HCM is characterized by the thickening of the heart muscle, while DCM involves the enlargement and weakening of the heart's chambers. The evidence for this association is considered moderate to strong in clinical genetics, as the variant is frequently identified in patients presenting with these conditions. Studies often focus on families where the condition is inherited in an autosomal dominant pattern, meaning that a single copy of the variant is sufficient to increase the risk of developing the disease. However, the clinical expression of the variant can be variable, meaning that even among family members who carry the same genetic change, the severity and age of onset of heart symptoms can differ significantly.
Population Frequency
The rs121913637 variant is extremely rare in the general population. Large-scale genomic databases, such as gnomAD, report that this variant is absent or found at near-zero frequencies across diverse ancestral groups. This rarity is consistent with its classification as a pathogenic variant associated with a serious, early-onset, or familial condition. Because it is not a common polymorphism found in the general public, it is rarely encountered outside of clinical settings where individuals are being tested due to a personal or family history of unexplained heart disease. Its absence in the general population suggests that it does not provide a selective advantage and is typically maintained in families through inheritance rather than being a widespread feature of the human genetic landscape.
Navigating Genetic Information
If you or a family member have been identified as a carrier of the rs121913637 variant, it is essential to consult with a cardiologist or a certified genetic counselor. This information is not a diagnosis in itself, but rather a clinical finding that requires professional interpretation in the context of your personal health history and physical examinations. Genetic testing for cardiomyopathy is a specialized field, and clinicians use these results to help manage risk, monitor heart function, and provide guidance to other family members who may also be at risk. You cannot determine your health status based on this variant alone, and you should never make changes to your medical care or lifestyle based on genetic data without direct supervision from your healthcare provider. Always discuss any concerns about heart health or genetic testing results with a qualified medical professional.
How common is this variant?
The rs121913637 variant is extremely rare in global populations and is absent or near-zero in large-scale reference databases like gnomAD.
Frequently asked questions
What is the TNNT2 gene?
The TNNT2 gene provides instructions for making cardiac troponin T, a protein essential for the contraction of heart muscle. It acts as a regulator that helps the heart muscle fibers slide past each other during a heartbeat.
Is rs121913637 a common genetic variant?
No, this variant is extremely rare. It is not found in the general population at any significant frequency and is typically only identified in clinical settings.
What does it mean if I have this variant?
Having this variant means you carry a genetic change that has been linked to an increased risk of heart muscle conditions like hypertrophic or dilated cardiomyopathy. You should discuss this finding with a cardiologist to understand what it means for your specific health situation.
Can I prevent heart disease if I have this variant?
While you cannot change your genetics, early identification allows for proactive medical monitoring. A cardiologist can help create a management plan to monitor your heart health and address any symptoms early.
Sources & further reading
Educational information only, last refreshed 9/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121913637?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in TNNT2
A rare splice-site variant in the cardiac troponin T gene identified in individuals of Oceanian ancestry with diverse cardiac phenotypes.
This variant is associated with cardiovascular phenotypes in ClinVar.
This variant is associated with cardiovascular phenotypes in ClinVar.
This variant is associated with cardiovascular phenotypes in ClinVar.